Key facts
- Rezilient’s last known valuation is $47.0M.
- It has raised $14.0M; the latest was Later Stage VC ($10.0M) in Sep 2024.
- Notable investors include Techstars, Matter (Consulting Services (B2B)), Missouri Technology Corporation, Bridge Ventures (Chicago), Acorn Pacific Ventures — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Rezilient
- ·The full record, as it builds
Funding rounds
No funding rounds for Rezilient are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rezilient
Operator of a telehealth platform intended to offer remote access to in-person care and other healthcare. The company's platform allows doctors to remotely control the positioning of medical devices in real-time to perform exams previously impossible to do remotely bringing the convenience of telehealth with the broad scope of in-person care, enabling individuals and families to get virtual access to their doctor as well as physical exams, labs and imaging.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2016
- Employees
- 18
- Website
- rezilienthealth.com/
- Ownership
- Privately Held (backing)
Rezilient doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rezilient shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rezilient in its N-PORT filings yet. We sweep new filings monthly.